Cyklokapron
Cyklokapron
- In our pharmacy, you can buy cyklokapron without a prescription, with delivery in 5–14 days throughout Canada (English). Discreet and anonymous packaging.
- Cyklokapron (tranexamic acid) is used to prevent or reduce bleeding (surgical/trauma bleeding, heavy menstrual bleeding, dental procedures in haemophilia) and is an antifibrinolytic that works by blocking plasminogen activation and inhibiting plasmin-mediated fibrin breakdown.
- The usual dose for adults is 1,000–1,500 mg orally or IV 2–3 times daily (tablets commonly 500 mg; heavy menstrual bleeding 1,000–1,300 mg up to 3 times/day for up to 5 days); pediatric dosing is weight-based (≈10–15 mg/kg per dose).
- Forms of administration: oral tablets (500 mg), oral solution (100 mg/mL, less common) and intravenous injection (100 mg/mL ampoules or vials).
- Onset time: IV effect within minutes; oral effect typically begins within 1–2 hours.
- Duration of action: plasma half-life ~2–3 hours; clinical antifibrinolytic effect commonly lasts about 6–8 hours, so dosing every 8 hours is typical.
- Alcohol warning: Do not consume alcohol while taking cyklokapron.
- The most common side effects are headache and nausea (other common effects include vomiting, diarrhoea, abdominal pain and muscle pain); rare but serious risks include seizures, visual disturbance and thromboembolic events.
- Would you like to try cyklokapron without a prescription?
Basic Cyklokapron Information
- INN (International Nonproprietary Name): Tranexamic acid
- Brand Names Available In Canada (English): Cyklokapron, Tranexamic acid, PrCyklokapron
- ATC Code: B02AA02
- Forms & Dosages: Tablets 500 mg (standard), 250 mg; Injection 100 mg/mL (ampoules/vials such as 1 g/10 mL)
- Manufacturers In Canada (English): Pfizer
- Registration Status In Canada (English): Health Canada approved (PrCyklokapron)
- OTC / Rx Classification: Prescription only (Rx)
Instructions, Warnings, And Daily-Life Integration
Are you wondering how to fit tranexamic acid into a busy Canadian life?
Only take cyklokapron under a prescription from your prescriber and follow the product label for the DIN and dosing details.
Bring the product leaflet and your provincial health card to any specialist or hospital appointment where TXA is discussed.
Store tablets below 25°C and keep them dry, as directed on the label.
Remember that injections (IV) are supplied and administered in hospital settings only.
If you miss a dose, take it when you remember unless it is near the time for the next dose; do not double up doses.
Discuss current oral contraceptive or hormone replacement therapy use, any history of blood clots (DVT, PE, stroke), seizures, or kidney disease with your prescriber before starting TXA.
If you live rurally, call ahead to arrange pharmacy pickup because chains like Shoppers Drug Mart, Rexall, London Drugs, and Jean Coutu may stock different pack sizes.
If you notice dizziness, visual changes, chest pain, leg swelling, sudden breathlessness, or new seizures, report them immediately.
- Emergency Checklist: chest pain; sudden shortness of breath; new leg swelling or pain; sudden severe headache or vision change; new seizure activity.
- Pre-use Steps: confirm prescription and DIN; check renal function if advised; inform prescriber about OCP/HRT and clot history; plan pharmacy pickup or delivery.
Everyday Use & Best Practices
How should tranexamic acid fit into a typical Canadian day?
Standard adult dosing ranges from 1,000 to 1,500 mg orally two to three times daily for indicated uses, so many people split doses between morning, noon and evening to match work, school and sleep schedules.
If your prescriber advises twice-daily dosing, aim for roughly 12 hours between doses.
If dosing three times daily, align doses with meals or waking hours to improve adherence and reduce missed doses.
Use a pillbox or smartphone reminder, which is especially useful for shift workers, students or those in remote communities.
Tranexamic acid may be taken with or without food.
If higher-dose tablets cause nausea, take them with a substantial breakfast typical in Canada, such as eggs and toast or a full cereal and fruit meal.
Avoid alcohol when treating heavy bleeding, because dehydration or alcohol-related effects can complicate clotting and recovery.
- Dosing Schedules: 1 g TID (morning/noon/evening) for many adult regimens; 1 g BID if prescribed twice daily.
- Troubleshooting: nausea after dose → take with food; missed dose → take unless near next dose; persistent side effects → contact prescriber.
Safety Priorities
Who should avoid tranexamic acid and what activities should be limited after starting it?
Absolute contraindications include known hypersensitivity to tranexamic acid, active intravascular clotting such as DVT or PE, a history of convulsions or seizures, and certain visual disorders like acquired defective colour vision.
People with renal impairment require dose reductions or extended dosing intervals because TXA is primarily excreted by the kidney.
Current use of oral contraceptives or anticoagulants raises baseline clotting concerns and should be reviewed by the prescriber.
If dizziness, visual disturbances or severe headaches occur after starting TXA, avoid driving and operating heavy machinery until symptoms resolve.
Workers in trades, hauling, long-haul driving, or heavy machinery roles should report new neurological symptoms and obtain clinical clearance before returning to high-risk tasks.
- Pre-Treatment Screening Checklist: prior clots; current OCP/HRT; seizure history; renal function if older or comorbid; list of current meds.
- Contraindications Vs Precautions: active thrombosis = contraindication; renal impairment = precaution with dosing adjustment; prior seizures = contraindication.
Dosage & Adjustments
What dose will your prescriber likely recommend, and who needs special attention?
Standard adult regimens are typically 1,000–1,500 mg orally two to three times daily for bleeding prophylaxis or treatment.
For heavy menstrual bleeding many adults take between 1,000 and 1,300 mg up to three times daily for up to five days per cycle.
In Canada you will commonly see PrCyklokapron or Cyklokapron packaging listing 500 mg tablets and IV ampoules 1 g/10 mL, so verify the DIN on the bottle before dispensing.
Elderly patients do not require routine dose reductions unless renal impairment is present.
When creatinine clearance is below 30 mL/min, reduce dose and/or extend the dosing interval because TXA is renally cleared.
Pediatric dosing is weight-based, usually 10–15 mg/kg per dose two to three times daily.
Complex patients with prior thromboembolism, disseminated intravascular coagulation, or those on anticoagulants should have specialist input before starting TXA.
| Indication | Typical Adult Regimen | Renal/Adjustment Notes |
|---|---|---|
| Bleeding Prophylaxis (surgery/hemophilia) | 1,000–1,500 mg PO/IV 2–3× daily; often around event and up to 7–8 days | Reduce dose if CrCl <30 mL/min |
| Heavy Menstrual Bleeding | 1,000–1,300 mg PO up to 3× daily for up to 5 days per cycle | Use caution if significant renal impairment |
| Pediatrics | 10–15 mg/kg/dose 2–3× daily | Weight-based dosing; adjust for renal function |
User Testimonials
What are Canadians saying about tranexamic acid on patient forums and boards?
Many patients report a rapid reduction in heavy menstrual bleeding after starting a 1 g three-times-daily regimen, often noticing improvement within one to two days.
Canadians with bleeding disorders report effective control of post-dental extraction bleeding when TXA is used alongside local haemostatic measures.
Common challenges mentioned on Reddit Canada and provincial health forums include nausea at higher doses, remembering doses during busy workweeks, and difficulties obtaining refills in rural pharmacies.
Cost and brand-versus-generic comparisons appear frequently, and bilingual labelling preferences are sometimes noted in Quebec threads.
- Pros: quick bleed reduction; fewer transfusions post-op; effective adjunct in dental procedures.
- Cons: nausea at higher doses; access issues in remote areas; rare clot concerns.
“Flow dropped noticeably by day two on 1 g TID.” — anonymized forum comment.
“Had to call my local Shoppers to order my pack ahead of time for a Friday pick-up.” — anonymized user note from a rural patient thread.
Buying Guide
Where do Canadians usually obtain tranexamic acid, and what should you check before purchasing?
In Canada, TXA is prescription-only, and common outlets include Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu and hospital pharmacies.
Availability may vary by province and by pack size for tablets; the typical tablet is 500 mg, and injectable formulations are for hospital use.
Ask your pharmacist to confirm the product name (Cyklokapron or PrCyklokapron) and the DIN at dispensing.
Prices depend on brand, package size and whether you have provincial or private coverage.
Check provincial drug benefit lists such as Ontario Drug Benefit, BC PharmaCare or RAMQ for possible coverage.
Online Canadian pharmacy portals may show comparable prices, but confirm they require a prescription and clearly show the DIN to ensure authenticity.
Note on cross-border products: Lysteda is a US brand name for oral tranexamic acid and differs in regulatory status and packaging; it may not be directly substitutable in Canada and import rules differ.
In our online pharmacy, cyklokapron is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
| Outlet | Typical Pack/Format | Price Notes |
|---|---|---|
| Shoppers Drug Mart | Cyklokapron 500 mg tablets (various pack sizes) | Check provincial coverage and private plans |
| Rexall | 500 mg tablets; hospital IV via hospitals | Prices vary by brand and plan |
| London Drugs | 500 mg tablets | Confirm DIN at dispensing |
| Jean Coutu | 500 mg tablets (Quebec stores) | Bilingual labelling options in Quebec |
What’s Inside And How It Works
What are the active and inactive components, and how does tranexamic acid stop bleeding?
The active ingredient is tranexamic acid, typically provided as 500 mg tablets for oral use and as 100 mg/mL injection solutions for IV use.
Inactive ingredients vary by manufacturer and appear on the product leaflet or blister pack, so check for any excipient allergies on the label.
Tranexamic acid is an antifibrinolytic in ATC class B02AA02 that inhibits the activation of plasminogen to plasmin.
By blocking fibrinolysis, TXA stabilizes fibrin clots at mucosal surfaces and surgical sites, reducing ongoing bleeding in conditions like heavy menstrual bleeding or post-operative blood loss.
| Item | Detail |
|---|---|
| Active Ingredient | Tranexamic acid (INN), typical tablet strength 500 mg |
| Injection Strength | 100 mg/mL (common ampoule 1 g/10 mL) |
| Mechanism | Antifibrinolytic that inhibits plasminogen activation, stabilizes clots |
Main Indications
When do Canadian prescribers commonly use tranexamic acid?
Health Canada has approved PrCyklokapron/Cyklokapron for prevention and treatment of bleeding where antifibrinolytic therapy is appropriate.
Common approved uses include surgical bleeding control, dental extractions in people with haemophilia and heavy menstrual bleeding.
Available forms include 500 mg tablets for outpatient use and 1 g/10 mL IV ampoules for hospital administration.
Canadian physicians sometimes use TXA off-label for topical applications in ENT or orthopaedic procedures and for short-term mucosal bleeding control.
Off-label use should be documented with informed consent and specialist input when appropriate.
| Indication | Typical Regimen | Setting |
|---|---|---|
| Surgical Bleeding Control | 1,000–1,500 mg PO/IV 2–3× daily around event | Hospital/perioperative |
| Heavy Menstrual Bleeding | 1,000–1,300 mg PO up to 3× daily for up to 5 days | Outpatient |
| Dental Extraction (hemophilia) | Start before and continue 5–8 days post-procedure | Outpatient with specialist advice |
Interaction Warnings
Which foods and drugs interact with tranexamic acid, and what should patients tell their prescriber?
There are no major food interactions, but alcohol may worsen bleeding and dehydration and should be avoided during acute treatment.
Caffeine does not interact pharmacologically with TXA but can worsen headaches, which are a common side effect.
Important drug interactions include concurrent use with systemic prothrombotic agents or clotting factor concentrates, which can increase thrombotic risk.
Concurrent hormonal contraceptives also increase baseline clot risk and warrant clinician assessment before prescribing TXA.
- Medication Checklist To Disclose: anticoagulants (warfarin, DOACs), antiplatelets, OCP/HRT, clotting factor concentrates, recent thrombotic events.
- Quick Reference: avoid combined use with prothrombotic agents unless specialist advises; monitor closely if on OCPs.
Latest Evidence & Insights
What does research say about tranexamic acid, and what should Canadian patients know?
High-quality international and Canadian studies show that TXA reduces bleeding in surgery, trauma and heavy menstrual bleeding.
Hospitals across Canada commonly include IV TXA in perioperative protocols to reduce transfusion rates where appropriate.
Short-term use is supported by evidence, but rare risks such as thromboembolism and seizures are documented and must be weighed against benefits.
For practical care, evidence supports short courses for heavy menses (commonly up to five days) and perioperative IV dosing according to local protocols.
Rural providers can use telehealth to consult specialists when balancing clot risk against bleeding control for patients far from specialty centres.
| Study Type | Outcome | Applicability To Canada |
|---|---|---|
| Perioperative Trials | Reduced blood loss and transfusion rates | Used in many Canadian hospital protocols |
| Menstrual Bleeding Studies | Significant reduction in menstrual blood loss within 24–48 hours | Supports outpatient 5-day regimens |
| Safety Reviews | Rare thrombotic and seizure events | Screening recommended for clot/seizure history |
Alternative Choices
What are alternatives to tranexamic acid, and when might they be chosen?
Aminocaproic acid (EACA) is a pharmacologic alternative and may be used when TXA is unavailable or not tolerated.
Non-pharmacologic options include mechanical compression, topical haemostatic agents, surgical cautery and local measures depending on the bleed site.
For heavy menstrual bleeding, hormonal options such as intrauterine devices, oral contraceptives and NSAIDs are commonly considered as alternatives or adjuncts.
- Pros Of TXA: established efficacy, oral and IV formulations, widely used in surgery and gynecology.
- Cons Of TXA: not suitable with active thrombosis or seizure history; requires renal dosing adjustments.
| Option | When To Consider | Notes |
|---|---|---|
| Aminocaproic Acid (EACA) | When TXA unavailable or intolerable | Less commonly used; different potency profile |
| Hormonal Therapies | Heavy menstrual bleeding, contraception desired | Consider fertility plans and side effects |
| Topical Haemostatics | Localised bleeding control during procedures | Often used in OR or dental settings |
Regulation Snapshot
How is tranexamic acid regulated and reimbursed across Canada?
Tranexamic acid marketed in Canada as Cyklokapron or PrCyklokapron is Health Canada approved and is prescription-only.
Products carry a Drug Identification Number (DIN); pharmacists and prescribers should verify the DIN on the bottle before dispensing.
Injectable formulations are regulated for hospital use and are administered under clinician supervision.
Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ determine reimbursement and coverage criteria that vary by indication and patient eligibility.
In Quebec, French labelling requirements apply and pharmacists should provide bilingual counselling where required.
| Authority | Role | Notes |
|---|---|---|
| Health Canada | Approval & regulation (PrCyklokapron) | Products carry a DIN; prescription-only |
| Provincial Programs | Reimbursement & coverage | ODB, PharmaCare, RAMQ vary by indication |
| Pharmacy Chains | Dispensing & stock management | Shoppers, Rexall, London Drugs, Jean Coutu stock varies by province |
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
FAQ
Can I take tranexamic acid while on birth control?
Short answer: discuss with your prescriber because both TXA and combined hormonal contraceptives raise clot risk, and the clinician will assess your individual factors before prescribing.
Will tranexamic acid affect fertility or future pregnancies?
Tranexamic acid is not a contraceptive and has no established long-term effects on fertility; avoid use in pregnancy unless a specialist advises it is necessary.
How soon will I notice it working?
Many patients report reduced bleeding within 24–48 hours for heavy menstrual bleeding and immediate effect when IV TXA is used in surgical settings.
- When To Call Your Prescriber: sudden chest pain, shortness of breath, new leg swelling, severe headache, visual changes, or new seizures.
Guidelines For Proper Use
What should pharmacists and patients check before starting and during tranexamic acid use?
Follow the prescriber’s directions and pharmacist counselling precisely, and verify the product name and tablet strength on the bottle.
Pharmacists should confirm Health Canada labelling and provincial formulary criteria before dispensing.
Outpatient use for heavy menstrual bleeding is commonly limited to up to five days per cycle, and treatment should be reassessed after three cycles or earlier if side effects occur.
Obtain baseline renal function testing if older or if kidney disease is suspected, and list all medications including OCPs, anticoagulants and supplements.
If IV TXA is prescribed, ensure the patient understands it will be given under clinical supervision in hospital.
- Printable Patient Checklist: confirm renal function if indicated; list all meds; note prior clots or seizures; arrange pharmacy access; keep emergency contacts handy.
